1,3-Benzodioxolylbutanamine (BDB), also known as 3,4-methylenedioxy-α-ethylphenethylamine or as J, is an entactogen of the phenethylamine, phenylisobutylamine, and MDxx families related to MDMA. http://www.erowid.org/library/books_online/pihkal/pihkal094.shtml
Use and effects In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists BDB's dose as 150 to 230mg orally and its duration as 4 to 8hours. BDB produces entactogenic, MDMA-like effects. Although pleasant and euphoric, BDB is also fairly sedating, and some users feel that the lack of stimulant effect makes it less enjoyable than other similar drugs. Additional side effects associated with BDB include nystagmus and dizziness.
Interactions
Pharmacology Pharmacodynamics Receptor and transporter interaction data have been reported for BDB. It acts as a serotonin–norepinephrine releasing agent (SNDRA) with only weak effects on dopamine. Animal studies and anecdotal reports have found that BDB is a slightly more potent serotonin releasing agent than its methylated sister compound methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J").
Chemistry BDB, also known as 1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-α-ethylphenethylamine, is a phenethylamine, α-ethylphenethylamine (phenylisobutylamine), and methylenedioxyphenethylamine (MDxx) related to MDMA. It is the α-ethyl analogue of 3,4-methylenedioxyphenethylamine (MDPEA) and 3,4-methylenedioxyamphetamine (MDA) and the 3,4-methylenedioxy derivative of α-ethylphenethylamine (AEPEA).
Synthesis The chemical synthesis of BDB has been described.
Analogues Analogues of BDB include MBDB (methyl-J), EBDB (ethyl-J), 1,3-benzodioxolylpentanamine (BDP; K), MBDP (methyl-K), EBDP (ethyl-K), and MPAP (PDBP; propyl-K), among others.
History BDB was first described in the scientific literature by at least 1973.
Society and culture Recreational use Rather than as a recreational drug itself, BDB is more commonly known as a metabolite of the N-alkylated analogues MBDB and ethylbenzodioxylbutanamine (EBDB; "Ethyl-J"), which have appeared in MDMA or "ecstasy" tablets. Although BDB itself has not been reported as being sold as "ecstasy", urine analysis of users suggest that this drug may have appeared as a street drug, though it is unclear whether the positive urine test for BDB resulted from consumption of BDB itself or merely as a metabolite of MBDB.
Legal status Germany BDB is illegal in Germany (Anlage I).
See also Substituted methylenedioxyphenethylamine Substituted phenylisobutylamine
References
External links J (BDB) - Isomer Design J (BDB) - PiHKAL - Erowid J (BDB) - PiHKAL - Isomer Design BDB (J) - The Shulgin Index